Wound Therapy System Advance Patients’ Mobility

Every patient treated with an Invia Motion receives a new device and accessories, providing up to 60 days of therapy, typically covering a patient's entire length of treatment. In addition, the flexible system offers a choice of constant or intermittent therapy modes, multiple pressure settings, and multiple drain options, which can be used with either antimicrobial gauze or polyurethane foam dressings.

The system provides a simple, easy canister replacement technique and a user-friendly interface. Other features include a suction capacity 1 Liter/min, five alarms for patient safety, and a discrete carry-case. The Invia Motion NPWT is a product of Medela (Zurich, Switzerland; www.medela.com), and is intended for use in hospitals, clinics, home care, and long term care settings on adult patients with specific acute and chronic wounds. NPWT is contraindicated in the presence of malignancy, untreated osteomyelitis, nonenteric and unexplored fistulas, necrotic tissue with eschar, and exposed vasculature, nerves, and organs.

“The portability of the Invia Motion not only protects patient dignity and well-being, but also improves patient compliance which greatly impacts improvement in overall patient outcomes,” said Medela medical research coordinator Rey Paglinawan, MSc.

NPWT applies controlled subatmospheric pressure to the local wound environment, using a sealed wound dressing connected to a vacuum pump. Due to its capacity to promote wound healing, NPWT has become standard practice in the field of advanced wound care. Although the body of evidence showing the beneficial effects of NPWT for healing wounds is accumulating, the precise wound healing mechanisms remain elusive.


Related Links:

Medela